Clinical Trial Update: Topical Infliximab in Eyes With Penetrating Keratoplasty [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial sponsored by Centre hospitalier de l'Université de Montréal is evaluating topical infliximab for glaucoma following penetrating keratoplasty. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Glaucoma Following Surgery | Phase 1, Phase 2 | Status: RECRUITING